Cerebral Palsy (CP)SGMT-CPNCT07753083
Structured Graphic Motor Therapy in Pediatric CP
A study testing Structured Graphic Motor Therapy (SGMT) and Conventional Upper-Limb Rehabilitation in people with Cerebral Palsy (CP), run by Armenian State Institute of Physical Culture and Sport at 1 site in Armenia.
Trial summary
Structured Graphic Motor Therapy (SGMT) is a novel task-oriented rehabilitation approach that uses standardized, progressively challenging drawing trajectories to improve upper-limb motor function in children with cerebral palsy. Read more about this study
- Who is it for?
- Ages 8 to 12 years
- Conditions the study is for
- Cerebral Palsy (CP)
- What is being tested?
- Structured Graphic Motor Therapy (SGMT) and Conventional Upper-Limb Rehabilitation
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 12 participants
- Where
- 1 siteArmenia
- Study dates
- 1 Apr 2025to 30 Nov 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 8 to 12 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Children aged 8 to 12 years. Confirmed diagnosis of cerebral palsy with unilateral or predominantly unilateral upper-limb motor impairment.
- Sufficient voluntary movement of the affected upper limb to grasp and manipulate a drawing instrument on a supported horizontal surface.
- Adequate visual, auditory, cognitive, and communication abilities to understand study instructions and complete standardized rehabilitation tasks.
- Ability to follow standardized two-step verbal commands. Written informed consent provided by a parent or legal guardian and age-appropriate assent provided by the child.
Who cannot join
- Uncontrolled epilepsy. Fixed upper-limb contracture preventing completion of the intervention tasks. Orthopedic surgery involving the upper limb within the previous 6 months. Botulinum toxin injection affecting the upper limb within the previous 6 months.
- Severe uncorrected visual impairment. Clinically significant upper-limb pain that interferes with task performance. Unstable medical condition that could interfere with participation. Participation in another intensive upper-limb rehabilitation program during the study period.
Trial locations and contacts
1 site in 1 country.
Armenia1 site
Armenian State Institute of Physical Culture and Sport
Yerevan, Yerevan, 0070
About this study
Official title: Structured Graphic Motor Therapy Facilitates Durable Motor Recovery Beyond Conventional Exercise: Evidence From a Comparative Pediatric Case Series
Structured Graphic Motor Therapy (SGMT) is a novel task-oriented rehabilitation approach that uses standardized, progressively challenging drawing trajectories to improve upper-limb motor function in children with cerebral palsy. This pilot randomized controlled trial will compare SGMT combined with conventional rehabilitation with conventional upper-limb rehabilitation alone over a 16-week intervention period. Standardized clinical assessments and quantitative image-derived measures of graphical motor performance will be used to evaluate changes in motor function, visuomotor coordination, and movement quality.
Read the detailed description
Upper-limb dysfunction is a major cause of activity limitation and reduced independence in children with cerebral palsy. Although conventional physiotherapy and occupational therapy improve motor performance, persistent deficits in fine motor control, visuomotor integration, and movement precision remain common. Structured Graphic Motor Therapy (SGMT) was developed as a standardized rehabilitation intervention based on principles of task-specific practice, motor learning, progressive overload, intrinsic visual feedback, and experience-dependent neuroplasticity. Rather than emphasizing artistic expression, SGMT employs individualized graphical trajectories of increasing complexity to promote coordinated upper-limb movement, continuous error correction, and sensorimotor integration.
This assessor-blinded pilot randomized controlled trial will enroll children aged 8-12 years with unilateral or predominantly unilateral cerebral palsy. Participants will be randomly assigned to receive either SGMT in addition to conventional rehabilitation or a time-matched program of conventional upper-limb rehabilitation alone. Both groups will complete four supervised 70-minute sessions per week for 16 weeks. Clinical outcomes will be assessed using the Melbourne Assessment of Unilateral Upper Limb Function (MA2) and selected Bruininks-Oseretsky Test of Motor Proficiency, Second Edition (BOT-2) subtests. Exploratory quantitative image-derived measures, including the Graphic Motor Performance Index (GMPI), will also be evaluated. Assessments will be performed at baseline, Week 8, Week 16, and 12-week follow-up to determine the feasibility, safety, and preliminary effectiveness of SGMT and to generate data for a future definitive multicenter randomized clinical trial.
These sections conform well to the style typically expected by ClinicalTrials.gov: the Brief Summary is concise, while the Detailed Description explains the scientific rationale, study design, intervention, outcomes, and objectives without presenting study results.
- Conditions
- Cerebral Palsy (CP)
- Being tested
- Structured Graphic Motor Therapy (SGMT), Conventional Upper-Limb Rehabilitation
- Keywords
- Cerebral Palsy, upper limb, Task oriented and visuomotor training, Structured Graphic Motor Therapy, Fine Motor Skills, Graphic Motor Performance
- Medical subject headings
- Cerebral Palsy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Structured Graphic Motor Therapy (SGMT)Behavioural
Structured Graphic Motor Therapy (SGMT) is a therapist-guided, task-oriented rehabilitation intervention using standardized, progressively individualized graphical trajectories to improve upper-limb motor function, visuomotor integration, movement precision, and motor learning. Training incorporates repetitive practice, intrinsic visual feedback, and progressive task complexity over 16 weeks.
Conventional Upper-Limb RehabilitationOther
Conventional upper-limb rehabilitation consists of active and active-assisted range-of-motion exercises, reaching, grasp-and-release practice, object transfer, forearm pronation and supination, wrist and finger exercises, bilateral upper-limb activities, and functional task practice delivered over 16 weeks.
| Study group | Role | What they receive |
|---|---|---|
| Structured Graphic Motor Therapy + Conventional Rehabilitation | Experimental | Participants receive Structured Graphic Motor Therapy (SGMT) in addition to conventional upper-limb rehabilitation. The intervention consists of therapist-guided, progressively individualized trajectory-based drawing tasks combined with standard rehabilitation. Participants complete four supervised 70-minute sessions per week for 16 weeks. Receives: Behavioral: Structured Graphic Motor Therapy (SGMT) |
| Conventional Upper-Limb Rehabilitation | Active comparator | Participants receive a time-matched program of conventional upper-limb rehabilitation consisting of active and active-assisted range-of-motion exercises, reaching activities, grasp-and-release practice, object manipulation, bilateral upper-limb activities, and functional task training. Participants complete four supervised 70-minute sessions per week for 16 weeks. Receives: Other: Conventional Upper-Limb Rehabilitation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Melbourne Assessment of Unilateral Upper Limb Function (MA2) Score
The primary outcome is the change in upper-limb motor function measured using the Melbourne Assessment of Unilateral Upper Limb Function, Second Edition (MA2). The MA2 evaluates movement quality, range of motion, dexterity, fluency, and accuracy during standardized unilateral upper-limb tasks in children with cerebral palsy. Higher scores indicate better upper-limb motor performance.
Measured: Baseline to Week 16 (end of intervention)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Aug 2026
- Study start1 Apr 2025
- Primary completion1 Oct 2025
- Study completion30 Nov 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cerebral Palsy (CP)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants are randomly assigned in a 1:1 ratio to either Structured Graphic Motor Therapy (SGMT) plus conventional upper-limb rehabilitation or conventional upper-limb rehabilitation alone. Both groups receive interventions concurrently for 16 weeks, with outcomes compared between parallel study arms.
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 12 participants (actual)
Sponsor and investigators
- Lead sponsor
- Armenian State Institute of Physical Culture and Sport
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Tigran Petrosyan, Armenian State Institute of Physical Culture and Sport
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07753083
- Sponsor's protocol ID
- 2025/0027
- Acronym
- SGMT-CP
- Status last verified
- Aug 2026
- First submitted
- 4 Aug 2026
- Last updated
- 7 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: Individual participant data (IPD) will not be publicly shared because of the small sample size and the potential risk of participant re-identification. De-identified data may be made available to qualified researchers upon reasonable request to the Principal Investigator, subject to institutional approval, applicable ethical requirements, and data use agreements.
Study at a glance
From the registry record, last updated by the sponsor on 7 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Structured Graphic Motor Therapy Facilitates Durable Motor Recovery Beyond Conventional Exercise: Evidence From a Comparative Pediatric Case Series
- ClinicalTrials.gov ID
- NCT07753083
- Acronym / sponsor ID
- SGMT-CP / 2025/0027
- Conditions
- Cerebral Palsy (CP)
- Keywords
- Cerebral Palsy, upper limb, Task oriented and visuomotor training, Structured Graphic Motor Therapy, Fine Motor Skills, Graphic Motor Performance
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 12 participants (actual)
- Lead sponsor
- Armenian State Institute of Physical Culture and SportUniversity, hospital or other
- Study start
- 1 Apr 2025 (actual)
- Primary completion
- 1 Oct 2025 (actual)
- Study completion
- 30 Nov 2025 (actual)
- First posted
- 7 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Structured Graphic Motor Therapy (SGMT) is a novel task-oriented rehabilitation approach that uses standardized, progressively challenging drawing trajectories to improve upper-limb motor function in children with cerebral palsy. This pilot randomized controlled trial will compare SGMT combined with conventional rehabilitation with conventional upper-limb rehabilitation alone over a 16-week intervention period. Standardized clinical assessments and quantitative image-derived measures of graphical motor performance will be used to evaluate changes in motor function, visuomotor coordination, and movement quality.
Detailed description
Upper-limb dysfunction is a major cause of activity limitation and reduced independence in children with cerebral palsy. Although conventional physiotherapy and occupational therapy improve motor performance, persistent deficits in fine motor control, visuomotor integration, and movement precision remain common. Structured Graphic Motor Therapy (SGMT) was developed as a standardized rehabilitation intervention based on principles of task-specific practice, motor learning, progressive overload, intrinsic visual feedback, and experience-dependent neuroplasticity. Rather than emphasizing artistic expression, SGMT employs individualized graphical trajectories of increasing complexity to promote coordinated upper-limb movement, continuous error correction, and sensorimotor integration.
This assessor-blinded pilot randomized controlled trial will enroll children aged 8-12 years with unilateral or predominantly unilateral cerebral palsy. Participants will be randomly assigned to receive either SGMT in addition to conventional rehabilitation or a time-matched program of conventional upper-limb rehabilitation alone. Both groups will complete four supervised 70-minute sessions per week for 16 weeks. Clinical outcomes will be assessed using the Melbourne Assessment of Unilateral Upper Limb Function (MA2) and selected Bruininks-Oseretsky Test of Motor Proficiency, Second Edition (BOT-2) subtests. Exploratory quantitative image-derived measures, including the Graphic Motor Performance Index (GMPI), will also be evaluated. Assessments will be performed at baseline, Week 8, Week 16, and 12-week follow-up to determine the feasibility, safety, and preliminary effectiveness of SGMT and to generate data for a future definitive multicenter randomized clinical trial.
These sections conform well to the style typically expected by ClinicalTrials.gov: the Brief Summary is concise, while the Detailed Description explains the scientific rationale, study design, intervention, outcomes, and objectives without presenting study results.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- Participants are randomly assigned in a 1:1 ratio to either Structured Graphic Motor Therapy (SGMT) plus conventional upper-limb rehabilitation or conventional upper-limb rehabilitation alone. Both groups receive interventions concurrently for 16 weeks, with outcomes compared between parallel study arms.
| Arm | Type | Receives |
|---|---|---|
| Structured Graphic Motor Therapy + Conventional Rehabilitation | Experimental | Behavioral: Structured Graphic Motor Therapy (SGMT)Participants receive Structured Graphic Motor Therapy (SGMT) in addition to conventional upper-limb rehabilitation. The intervention consists of therapist-guided, progressively individualized trajectory-based drawing tasks combined with standard rehabilitation. Participants complete four supervised 70-minute sessions per week for 16 weeks. |
| Conventional Upper-Limb Rehabilitation | Active comparator | Other: Conventional Upper-Limb RehabilitationParticipants receive a time-matched program of conventional upper-limb rehabilitation consisting of active and active-assisted range-of-motion exercises, reaching activities, grasp-and-release practice, object manipulation, bilateral upper-limb activities, and functional task training. Participants complete four supervised 70-minute sessions per week for 16 weeks. |
Who may qualify
- Ages
- 8 to 12 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (4 listed)
- Children aged 8 to 12 years. Confirmed diagnosis of cerebral palsy with unilateral or predominantly unilateral upper-limb motor impairment.
- Sufficient voluntary movement of the affected upper limb to grasp and manipulate a drawing instrument on a supported horizontal surface.
- Adequate visual, auditory, cognitive, and communication abilities to understand study instructions and complete standardized rehabilitation tasks.
- Ability to follow standardized two-step verbal commands. Written informed consent provided by a parent or legal guardian and age-appropriate assent provided by the child.
Key exclusion criteria (2 listed)
- Uncontrolled epilepsy. Fixed upper-limb contracture preventing completion of the intervention tasks. Orthopedic surgery involving the upper limb within the previous 6 months. Botulinum toxin injection affecting the upper limb within the previous 6 months.
- Severe uncorrected visual impairment. Clinically significant upper-limb pain that interferes with task performance. Unstable medical condition that could interfere with participation. Participation in another intensive upper-limb rehabilitation program during the study period.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Structured Graphic Motor Therapy (SGMT)Structured Graphic Motor Therapy (SGMT) is a therapist-guided, task-oriented rehabilitation intervention using standardized, progressively individualized graphical trajectories to improve upper-limb motor function, visuomotor integration, movement precision, and motor learning. Training incorporates repetitive practice, intrinsic visual feedback, and progressive task complexity over 16 weeks. | Behavioural | Structured Graphic Motor Therapy + Conventional Rehabilitation |
| Conventional Upper-Limb RehabilitationConventional upper-limb rehabilitation consists of active and active-assisted range-of-motion exercises, reaching, grasp-and-release practice, object transfer, forearm pronation and supination, wrist and finger exercises, bilateral upper-limb activities, and functional task practice delivered over 16 weeks. | Other | Conventional Upper-Limb Rehabilitation |
Primary outcome
Change in Melbourne Assessment of Unilateral Upper Limb Function (MA2) Score
Time frame: Baseline to Week 16 (end of intervention)
The primary outcome is the change in upper-limb motor function measured using the Melbourne Assessment of Unilateral Upper Limb Function, Second Edition (MA2). The MA2 evaluates movement quality, range of motion, dexterity, fluency, and accuracy during standardized unilateral upper-limb tasks in children with cerebral palsy. Higher scores indicate better upper-limb motor performance.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Aug 2026.
- Official website of the Armenian State Institute of Physical Culture and Sport, the study sponsor and participating research institution.Link provided by the sponsor.
- Individual participant dataSharing planned: Undecided. Individual participant data (IPD) will not be publicly shared because of the small sample size and the potential risk of participant re-identification. De-identified data may be made available to qualified researchers upon reasonable request to the Principal Investigator, subject to institutional approval, applicable ethical requirements, and data use agreements.
Related trials for Cerebral Palsy (CP)
Not yet recruiting
Ayres Sensory Integration Intervention for Children With Cerebral Palsy
Cerebral Palsy (CP)
Recruiting
Short-Term Effects of Manual Therapy Prior to Neuromotor Therapy in Children With Cerebral Palsy
Cerebral Palsy (CP), Unilateral Spastic Cerebral Palsy
Active, not recruiting
Virtual Reality Vs Postural Control Training in Children With Cerebral Palsy
Children With Hemiplegic cp
Enrolling by invitationObservational study
Intelligent Physiological Monitoring to Predict Preterm Brain Injury
Cerebral Palsy (CP), Intraventricular Hemorrhage Neonatal
Recruiting
Acceptability of Paediatric Wrist Orthoses Through Co-design
Cerebral Palsy (CP), Brain Injuries
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Structured Graphic Motor Therapy (SGMT) and Conventional Upper-Limb Rehabilitation in people with Cerebral Palsy (CP), run by Armenian State Institute of Physical Culture and Sport at 1 site in Armenia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Armenia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Melbourne Assessment of Unilateral Upper Limb Function (MA2) Score (time frame: Baseline to Week 16 (end of intervention)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Aug 2026; AzTrials last refreshed its copy on 30 Oct 2026.